Sponsor pipeline

Transcend Therapeutics clinical trial pipeline

3 active trials 2 recruiting 3 Phase 3 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-09-23	NCT07836647 An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD	Phase 3	Recruiting

Phase 3

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT07836647	An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD	Post Traumatic Stress Disorder	Recruiting	2026-09-23
NCT07456696	An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)	Post Traumatic Stress Disorder	Recruiting	2026-09-17
NCT07670702	An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD	Post Traumatic Stress Disorder	Enrolling by Invitation	2026-09-04

Get alerts when Transcend Therapeutics's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.